Skip to content

Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia

Effect of Adding Escalating Doses of a Novel Highly Viscous Polysaccharide to Either a Liquid or a Solid Test Meal on Post Prandial Glycemia in Healthy Subjects: Determination of the Glycemic Reduction Index Potential (GRIP)

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00801814
Enrollment
20
Registered
2008-12-04
Start date
2006-04-30
Completion date
2006-08-31
Last updated
2008-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Glucose, Postprandial

Keywords

viscous, fibre, polysaccharide, blood glucose, post prandial

Brief summary

To determine palatability and extent to which escalating doses of a novel highly viscous polysaccharide \[NVP\] reduces postprandial glycemia when added to a liquid and a solid meal.

Interventions

DIETARY_SUPPLEMENTPolyGlycopleX (PG)

5.0 grams of PGX

DIETARY_SUPPLEMENTPolyGlycopleX

7.5 grams of PGX

DIETARY_SUPPLEMENTControl

0g of PGX

DIETARY_SUPPLEMENTSecond Control

0g of PGX

DIETARY_SUPPLEMENTPolyGlycopleX (PGX)

2.5 grams of PGX

Sponsors

InovoBiologic Inc.
CollaboratorINDUSTRY
Canadian Center for Functional Medicine
CollaboratorOTHER
Glycemic Index Laboratories, Inc
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy individuals * 18-75 years old * BMI less than 35 kg/m2

Exclusion criteria

* Medications influencing gastrointestinal function * Pregnancy

Design outcomes

Primary

MeasureTime frame
postprandial glycemiaAcute study measuring postprandial glucose levels over 2 hours

Secondary

MeasureTime frame
The glucose reduction index potential (GRIP). The GRIP factor is the reduction in glycemic index units per gram of fiber.Data analysis

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026